Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery’s Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments
The Beauty Health Company (NASDAQ:SKIN), known for its flagship brand Hydrafacial™, has announced a video poster abstract presentation at the upcoming American Society for Dermatologic Surgery (ASDS) meeting in Orlando, Florida from October 17-20, 2024. The presentation will focus on the efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser and intense pulsed light (IPL) full-face treatments.
CEO Marla Beck highlighted the significance of this presentation, stating that it will provide scientific validation for the complementary effects of Hydrafacial with other aesthetic treatments. The study, titled 'A Randomized, Split-face, Prospective, Study to Assess the Efficacy and Safety of Hydradermabrasion after 1927nm Non-ablative Fractional Laser or Intense Pulsed Light Full-Face Treatments', will be presented by Dr. Michael Abrouk. The abstract emphasizes the synergistic effects of Hydrafacial when combined with non-ablative laser and IPL treatments, showcasing its ability to enhance overall skin quality, hydration, and treatment outcomes.
La Beauty Health Company (NASDAQ:SKIN), conosciuta per il suo marchio di punta Hydrafacial™, ha annunciato una presentazione di abstract video poster alla prossima riunione dell'American Society for Dermatologic Surgery (ASDS) che si terrà a Orlando, Florida, dal 17 al 20 ottobre 2024. La presentazione si concentrerà sull'efficacia e la sicurezza dei trattamenti Hydrafacial combinati con il laser frazionato non ablativo e i trattamenti di luce pulsata intensa (IPL) per il viso completo.
La CEO Marla Beck ha sottolineato l'importanza di questa presentazione, affermando che fornirà una validazione scientifica degli effetti complementari di Hydrafacial con altri trattamenti estetici. Lo studio, intitolato 'Uno Studio Randomizzato, Split-face, Prospective, per Valutare l'Efficacia e la Sicurezza dell'Idradermabrasione dopo Trattamenti Laser Frazionati Non Ablativi a 1927nm o Trattamenti di Luce Pulsata Intensa per il Viso Completo', sarà presentato dal Dr. Michael Abrouk. L'abstract enfatizza gli effetti sinergici di Hydrafacial quando combinato con trattamenti laser non ablativi e IPL, evidenziando la sua capacità di migliorare la qualità complessiva della pelle, l'idratazione e i risultati del trattamento.
La Beauty Health Company (NASDAQ:SKIN), conocida por su marca insignia Hydrafacial™, ha anunciado una presentación de resumen en video en la próxima reunión de la American Society for Dermatologic Surgery (ASDS) que se llevará a cabo en Orlando, Florida, del 17 al 20 de octubre de 2024. La presentación se centrará en la eficacia y seguridad de los tratamientos Hydrafacial combinados con láser fraccionado no ablativo y tratamientos de luz pulsada intensa (IPL) para el rostro completo.
La CEO Marla Beck destacó la importancia de esta presentación, afirmando que proporcionará validación científica de los efectos complementarios de Hydrafacial con otros tratamientos estéticos. El estudio, titulado 'Un Estudio Aleatorizado, de Cara Dividida y Prospectivo para Evaluar la Eficacia y Seguridad de la Hidrodermoabrasión después de Tratamientos de Láser Fraccionado No Ablativo de 1927nm o Tratamientos de Luz Pulsada Intensa para el Rostro Completo', será presentado por el Dr. Michael Abrouk. El resumen enfatiza los efectos sinérgicos de Hydrafacial cuando se combina con tratamientos de láser no ablativo y IPL, mostrando su capacidad para mejorar la calidad general de la piel, la hidratación y los resultados del tratamiento.
뷰티 헬스 컴퍼니 (NASDAQ:SKIN), 그들의 주력 브랜드인 Hydrafacial™로 유명한,가 오는 미국 피부과 수술학회 (ASDS) 회의에서 비디오 포스터 초록 발표를 할 것이라고 발표했습니다. 이 회의는 플로리다주 오르란도에서 2024년 10월 17일부터 20일까지 개최됩니다. 발표는 비닐레이저 비절제 및 강한 간섭광 (IPL) 전체얼굴 치료와 결합된 Hydrafacial 치료의 효과와 안전성에 초점을 맞출 것입니다.
CEO 마를라 벡은 이 발표의 중요성을 강조하며, Hydrafacial이 다른 미용 치료와 함께 했을 때의 보완적 효과에 대한 과학적 검증을 제공할 것이라고 밝혔습니다. '1927nm 비절제 프락셔널 레이저 또는 강한 간섭광 전체얼굴 치료 후 Hydradermabrasion의 효과와 안전성을 평가하기 위한 무작위, 분할 얼굴, 전향적 연구'라는 제목의 연구는 마이클 아브루크 박사가 발표할 예정입니다. 초록은 비절제 레이저 및 IPL 치료와 결합된 Hydrafacial의 시너지 효과를 강조하며, 전반적인 피부 품질, 수분 및 치료 결과를 향상시키는 능력을 보여줍니다.
La Beauty Health Company (NASDAQ:SKIN), connue pour sa marque phare Hydrafacial™, a annoncé une présentation d'abstrait vidéo lors de la prochaine réunion de l'American Society for Dermatologic Surgery (ASDS) à Orlando, Floride, du 17 au 20 octobre 2024. La présentation se concentrera sur l'efficacité et la sécurité des traitements Hydrafacial combinés avec le laser fractionné non ablatif et les traitements à lumière pulsée intense (IPL) sur l'ensemble du visage.
La CEO Marla Beck a souligné l'importance de cette présentation, affirmant qu'elle fournira une validation scientifique des effets complémentaires de Hydrafacial avec d'autres traitements esthétiques. L'étude, intitulée 'Une Étude Randomisée, à Visage Divisé, Prospective pour Évaluer l'Efficacité et la Sécurité de l'Hydradermabrasion après des Traitements au Laser Fractionné Non Ablatif de 1927nm ou des Traitements à Lumière Pulsée Intense sur le Visage Complet', sera présentée par le Dr. Michael Abrouk. L'extrait souligne les effets synergiques de Hydrafacial lorsqu'il est combiné avec des traitements au laser non ablatif et IPL, démontrant sa capacité à améliorer la qualité globale de la peau, l'hydratation et les résultats des traitements.
Die Beauty Health Company (NASDAQ:SKIN), bekannt für ihre Hauptmarke Hydrafacial™, hat eine Video-Poster-Abriss-Präsentation bei der kommenden American Society for Dermatologic Surgery (ASDS)-Tagung in Orlando, Florida, vom 17. bis 20. Oktober 2024 angekündigt. Die Präsentation wird sich auf die Efficacy und Sicherheit von Hydrafacial-Behandlungen in Kombination mit nicht-ablativen fraktionierten Lasern und intensiven gepulsten Licht (IPL) Ganzbehandlung konzentrieren.
CEO Marla Beck hob die Bedeutung dieser Präsentation hervor und erklärte, dass sie eine wissenschaftliche Validierung der komplementären Effekte von Hydrafacial mit anderen ästhetischen Behandlungen liefern wird. Die Studie mit dem Titel 'Eine randomisierte, geteilte Gesicht, prospektive Studie zur Bewertung der Wirksamkeit und Sicherheit von Hydradermabrasion nach 1927 nm nicht-ablativen fraktionierten Laser oder intensiven gepulsten Lichtbehandlungen für das gesamte Gesicht' wird von Dr. Michael Abrouk präsentiert. Das Abstract betont die synergistischen Effekte von Hydrafacial in Kombination mit nicht-ablativen Laser- und IPL-Behandlungen und zeigt deren Fähigkeit, die Gesamtqualität der Haut, die Hydratation und die Behandlungsergebnisse zu verbessern.
- Presentation at ASDS meeting provides scientific validation for Hydrafacial's efficacy
- Study demonstrates synergistic effects of Hydrafacial with non-ablative laser and IPL treatments
- Potential for new compelling Hydrafacial treatment protocol in the medical field
- None.
Insights
This presentation at the ASDS meeting represents a significant step in validating Hydrafacial's efficacy when combined with other aesthetic treatments. The study's focus on combining Hydrafacial with non-ablative fractional laser and IPL treatments is particularly noteworthy for several reasons:
- It provides scientific evidence to support anecdotal claims from providers about Hydrafacial's complementary effects.
- The research could potentially expand Hydrafacial's market by positioning it as an enhancer for other popular treatments.
- The study's design (randomized, split-face, prospective) suggests a robust methodology, which could lend credibility to the findings.
However, it's important to note that while this research is promising, its impact on BeautyHealth's (SKIN) financial performance may not be immediate. The actual presentation is still months away and the market adoption of new protocols can take time. Investors should monitor how quickly dermatologists and aestheticians incorporate these findings into their practices, as this will be a key indicator of potential revenue growth.
"This presentation on the clinical efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser or IPL full-face treatments represents a significant milestone for Hydrafacial,” said Marla Beck, Chief Executive Officer of BeautyHealth. “Although Hydrafacial treatments are incredibly effective on their own, providers frequently report that they complement other aesthetic treatments perfectly. Now, scientific data will validate what providers have observed in their treatment rooms for years, introducing a new compelling Hydrafacial treatment protocol for those in the medical field."
The following data will be presented:
Title: A Randomized, Split-face, Prospective, Study to Assess the Efficacy and Safety of Hydradermabrasion after 1927nm Non-ablative Fractional Laser or Intense Pulsed Light Full-Face Treatments
Presenting Author: Michael Abrouk, MD
Format: Video Abstract
- Highlights the synergistic effects of Hydrafacial when combined with non-ablative laser and IPL treatments.
- Hydrafacial not only delivers exceptional results as a standalone treatment, but it also helps enhance the overall appearance of skin quality, hydration, and the outcomes of other advanced procedures.
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241017137338/en/
Hydrafacial Media: Marina Maher Communications | Hydrafacial@hellommc.com
Source: The Beauty Health Company
FAQ
What is the focus of Hydrafacial's presentation at the 2024 ASDS Annual Meeting?
Who is presenting the Hydrafacial study at the 2024 ASDS Annual Meeting?
When and where is the 2024 ASDS Annual Meeting featuring Hydrafacial's presentation?
What are the potential benefits of combining Hydrafacial with non-ablative laser and IPL treatments according to the study (SKIN)?
